Cytosine diphosphate (CDP) diacylglycerol-inositol 3-phosphatidyltransferase
RxNorm 20465
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 20465 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: Cytosine diphosphate (CDP) diacylglycerol-inositol 3-phosphatidyltransferase.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SY
Synonym (SY):
CDP-diglyceride-inositol phosphatidyltransferase
(Atom ID: 396704)
PT
Designated preferred name (PT):
CDPdiacylglycerol-inositol 3-phosphatidyltransferase
(Atom ID: 396695)
SY
Synonym (SY):
Cytosine diphosphate (CDP) diacylglycerol-inositol 3-phosphatidyltransferase
(Atom ID: 2545318)
SY
Synonym (SY):
Cytosine diphosphate diacylglycerol-inositol 3-phosphatidyltransferase
(Atom ID: 4247819)
FN
Full form of descriptor (FN):
Cytosine diphosphate diacylglycerol-inositol 3-phosphatidyltransferase (substance)
(Atom ID: 4247820)
SY